OTCMKTS:DSRLF

DiaSorin (DSRLF) Stock Forecast, Price & News

$91.00

-0.60 (-0.66%)

(As of 09/22/2023 ET)

Compare

Today's Range: $91.00
▼
$91.00
50-Day Range: $91.00
▼
$97.98
52-Week Range: $91.00
▼
$147.15

Volume: 35 shs
Average Volume: 13 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $201.25

Profile Analyst Ratings Chart Competitors Headlines Short Interest

About DiaSorin (OTCMKTS:DSRLF) Stock

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

DSRLF Price History

30 days | 90 days | 365 days | Advanced Chart

DSRLF Stock News Headlines

July 27, 2023 | msn.com

DiaSorin S.p.A. reports 1H results

May 9, 2023 | msn.com

DiaSorin confirms 2023 guidance after Q1 results

September 23, 2023 | Stansberry Research (Ad)

U.S. "Shadow Banks" About to Blow up again?

Analyst who called Lehman crash says our biggest calamities (1907, 1929, 2007, etc) all start in the same spot--and it’s about to happen again. More here.

April 6, 2023 | barrons.com

DiaSorin S.p.A.

March 29, 2023 | seekingalpha.com

DiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call Transcript

March 4, 2023 | seekingalpha.com

DiaSorin: Overvalued Italian Healthcare Company

February 15, 2023 | wsj.com

Cytek(R) Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

February 13, 2023 | finance.yahoo.com

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

September 23, 2023 | Stansberry Research (Ad)

U.S. "Shadow Banks" About to Blow up again?

Analyst who called Lehman crash says our biggest calamities (1907, 1929, 2007, etc) all start in the same spot--and it’s about to happen again. More here.

October 31, 2022 | reuters.com

DIAS.MI - DiaSorin SpA | Stock Price & Latest News | Reuters

August 8, 2022 | seekingalpha.com

DiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q2 2022 Results - Earnings Call Transcript

October 23, 2021 | finance.yahoo.com

Southwest Airlines Company (LUV) stock forecast and price target

August 2, 2021 | seekingalpha.com

DiaSorin S.p.A. 2021 Q2 - Results - Earnings Call Presentation

April 21, 2021 | businesswire.com

QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early ...

April 13, 2021 | finance.yahoo.com

Luminex (LMNX) to Get Acquired by DiaSorin for Around $1.8B

April 12, 2021 | finance.yahoo.com

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Luminex Corporation Buyout

April 12, 2021 | markets.businessinsider.com

DiaSorin To Buy Luminex For $1.8 Bln

April 12, 2021 | finance.yahoo.com

Shareholder Alert: Ademi LLP investigates whether Luminex Corporation has obtained a Fair Price in its transaction with DiaSorin

April 12, 2021 | investing.com

Luminex Jumps on $1.8 Billion Deal from Italy’s DiaSorin

April 12, 2021 | msn.com

Luminex Jumps on $1.8 Billion Pact to Be Bought by DiaSorin

April 12, 2021 | finance.yahoo.com

UPDATE 1-Shares in Italy's DiaSorin jump after $1.8 bln Luminex acquisition

April 11, 2021 | bloomberg.com

DiaSorin to Buy Covid-19 Test Maker Luminex for $1.8 Billion

March 13, 2021 | seekingalpha.com

DiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q4 2020 Results - Earnings Call Transcript

March 11, 2021 | seekingalpha.com

DiaSorin S.p.A. reports FY results

February 25, 2021 | msn.com

DiaSorin Weighs Diagnostics Deal for Luminex

November 13, 2020 | seekingalpha.com

DiaSorin S.p.A. 2020 Q3 - Results - Earnings Call Presentation

November 11, 2020 | marketwatch.com

Display Dielectric Materials Market Trends to Expand Significantly by 2027 | DiaSorin S.p.A, Becton, Dickinson and Company, SA Scientific

See More Headlines

Receive DSRLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter.

DSRLF Company Calendar

Today: 9/23/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Private households
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:DSRLF
CUSIP: N/A
CIK: N/A
Web: www.diasoringroup.com
Phone: 391614871
Fax: N/A
Employees: 3,358
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $201.25
High Stock Price Forecast: $201.25
Low Stock Price Forecast: $201.25
Forecasted Upside/Downside: +119.7%
Consensus Rating: Reduce
Rating Score (0-4): 1.67
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $1.46 billion
Price / Sales: 3.42
Cash Flow: $9.80 per share
Price / Cash Flow: 9.35
Book Value: $29.58 per share
Price / Book: 3.10

Miscellaneous

Outstanding Shares: 54,710,000
Free Float: N/A
Market Cap: $5.01 billion
Optionable: Not Optionable
Beta: 0.39

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Carlo Rosa (Age 57)
CEO, GM & Exec. Director
Comp: $1.88M

Dr. Chen Menachem Even (Age 60)
Chief Commercial Officer, Sr. Corp. VP of Commercial Operations & Exec. Director
Comp: $919.27k

Mr. Piergiorgio Pedron (Age 52)
Sr. Corp. VP, CFO & Corp. Accounting Documents Officer

Mr. Fabrizio Piercarlo Bonelli
Corp. VP & Chief Technology Officer

Dr. Riccardo Fava
Corp. VP of Communication & Investor Relations

Mr. Ulisse Spada
Corp. VP, Head of the Legal Department, Sec. & Gen. Counsel

Mr. Stefano Ronchi (Age 63)
Sr. Corp. VP of HR

Mr. Ugo Gay (Age 58)
Chief Exec. Officer of DiaSorin Italia S.p.A.

Mr. Angelo Rago (Age 60)
Pres of Luminex Corp.

Key Competitors

View All Competitors

DSRLF Stock - Frequently Asked Questions

Should I buy or sell DiaSorin stock right now?: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DiaSorin in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" DSRLF shares.
View DSRLF analyst ratings or view top-rated stocks.
What is DiaSorin's stock price forecast for 2023?: 6 brokerages have issued twelve-month target prices for DiaSorin's stock. Their DSRLF share price forecasts range from $201.25 to $201.25. On average, they anticipate the company's stock price to reach $201.25 in the next year. This suggests a possible upside of 119.7% from the stock's current price.
View analysts price targets for DSRLF or view top-rated stocks among Wall Street analysts.
How have DSRLF shares performed in 2023?: DiaSorin's stock was trading at $147.15 at the beginning of 2023. Since then, DSRLF stock has decreased by 37.8% and is now trading at $91.5995.
View the best growth stocks for 2023 here.
What is DiaSorin's stock symbol?: DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF."

How do I buy shares of DiaSorin?: Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is DiaSorin's stock price today?: One share of DSRLF stock can currently be purchased for approximately $91.60.
How much money does DiaSorin make?: DiaSorin (OTCMKTS:DSRLF) has a market capitalization of $5.01 billion and generates $1.46 billion in revenue each year.
How many employees does DiaSorin have?: The company employs 3,358 workers across the globe.
How can I contact DiaSorin?: DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The official website for the company is www.diasoringroup.com. The company can be reached via phone at 391614871 or via email at ines.diterlizzi@diasorin.it.

This page (OTCMKTS:DSRLF) was last updated on 9/23/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

DiaSorin (DSRLF) Stock Forecast, Price & News

About DiaSorin (OTCMKTS:DSRLF) Stock

DSRLF Price History

DSRLF Stock News Headlines

DSRLF Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

DSRLF Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info